PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-03-21

Date Title Company
21-Mar-2023 Icosagen Acquires the Carterra LSA Instrument to Significantly Enhance Its Antibody Screening Capabilities in the Discovery and Development of New Therapeutic and Diagnostic Antibodies Icosagen Group
21-Mar-2023 Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions Vaccitech
21-Mar-2023 Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO Tiziana Life Sciences
21-Mar-2023 AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline AC Immune
21-Mar-2023 Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia Karuna Therapeutics
21-Mar-2023 'More Advanced Diagnostic Testing is Crucial for Preventing an Avian Flu Pandemic’ Pictura Bio
21-Mar-2023 SpyBiotech Receives Grant to Advance Novel SpyVector Platform That Improves Efficacy and Boosting Capability of Adenovirus-based Vaccines Against Current and Future Pandemic Viruses SpyBiotech
21-Mar-2023 LYNPARZA (OLAPARIB) APPROVED IN THE UK AS COMBINATION THERAPY FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHEN CHEMOTHERAPY IS NOT CLINICALLY INDICATED AstraZeneca
21-Mar-2023 2023 PM Society Awards – Winners Announced PM Society
21-Mar-2023 MHRA to streamline clinical trial approvals in biggest overhaul of trial regulation in 20 years MHRA
21-Mar-2023 Intrauterine Insemination Devices Market is expected to be valued at US$ 57.5 million by 2033 | FMI Analyst MARKITWIRED
21-Mar-2023 Altasciences Selects Proscia To Accelerate The Development Of Life-Saving Drugs Proscia
21-Mar-2023 Sustainability takes centre stage for Tower Cold Chain at LogiPharma Tower Cold Chain
21-Mar-2023 Virtual Reality Transforms EDI Training at Chelsea and Westminster Hospital NHS Foundation Trust CW+
21-Mar-2023 LYNPARZA (OLAPARIB) APPROVED IN THE UK AS COMBINATION THERAPY FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHEN CHEMOTHERAPY IS NOT CLINICALLY INDICATED AstraZeneca and MSD
21-Mar-2023 Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery BHV Partners
21-Mar-2023 Rancho Biosciences Welcomes Regeneron as the Newest Member to Its Single Cell Data Science Consortium Newswire
21-Mar-2023 LighthouseAI Announces Innovative AI-Based Compliance Solution for the Life Sciences Industry Newswire
21-Mar-2023 Exeliom Biosciences Announces First Patient Enrolled in Phase 1 Study for the Maintenance in Remission in Adult Patients With Mild to Moderate Crohn's Disease Newswire
21-Mar-2023 Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023 Evotec SE